Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...